Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.
D000208:Acute Disease; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D007958:Leukocyte Count; D008099:Liver / Q000503:physiopathology; D008297:Male; D010919:Placebos; D013792:Thalidomide / Q000627:therapeutic use*; D014556:Urine / Q000032:analysis
D001779:Blood Coagulation Factors; D010919:Placebos; D013792:Thalidomide; D002784:Cholesterol; D001663:Bilirubin